Editorial: New therapeutics for soft tissue sarcomas

Front Oncol. 2023 Oct 16:13:1297215. doi: 10.3389/fonc.2023.1297215. eCollection 2023.

Authors

Marla Weetall¹, Mark Rance¹, Matthew Ingham², Brian A Van Tine^{3

4

5}

Affiliations

¹ Pharmacology and Biomarkers, PTC Therapeutics (United States), South Plainfield, NJ, United States.
² Clinical Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
³ Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, United States.
⁴ Siteman Cancer Center, St. Louis, MO, United States.
⁵ Division of Pediatric Hematology and Oncology, St. Louis Children's Hospital, St. Louis, MO, United States.

No abstract available

Keywords: chemotherapy; combination (combined) therapy; immunotherapy; personalized medicine; sarcoma.

Publication types

Editorial